Systems biology based drug repositioning for development of cancer therapy
Review article, 2021
Cancer
Systems biology
Drug repositioning
Network-based approaches
Signature-based approaches
Author
Beste Turanli
Royal Institute of Technology (KTH)
Istanbul Medeniyet University
Marmara University
Ozlem Altay
Royal Institute of Technology (KTH)
Jan Borén
Sahlgrenska University Hospital
Hasan Turkez
Erzurum Technical University
Jens B Nielsen
Chalmers, Biology and Biological Engineering, Systems and Synthetic Biology
Mathias Uhlen
Royal Institute of Technology (KTH)
Kazim Y. Arga
Marmara University
Adil Mardinoglu
King's College London
Royal Institute of Technology (KTH)
Seminars in Cancer Biology
1044-579X (ISSN) 1096-3650 (eISSN)
Vol. 68 47-58Subject Categories
Pharmaceutical Sciences
Biomedical Laboratory Science/Technology
Social and Clinical Pharmacy
DOI
10.1016/j.semcancer.2019.09.020
PubMed
31568815